Breaking News
Get 50% Off 0
NVDA gained a massive 197% since our AI first added it in November - is it time to sell? 🤔 Read more
Close

Shaanxi Meibang Pharmaceutical Group Co Ltd (605033)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
12.42 -0.23    -1.82%
03:00:00 - Closed. Currency in CNY ( Disclaimer )
Type:  Equity
Market:  China
ISIN:  CNE100005071 
  • Volume: 656,800
  • Bid/Ask: 12.41 / 12.42
  • Day's Range: 12.37 - 12.73
Shaanxi Meibang Pharmaceutical 12.42 -0.23 -1.82%

Shaanxi Meibang Pharmaceutical Group Co Ltd Company Profile

 
Get an in-depth profile of Shaanxi Meibang Pharmaceutical Group Co Ltd, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryChemicals
SectorBasic Materials
Employees

1025

Equity Type

ORD

Shaanxi Meibang Pharmaceutical Group Co., Ltd., together with its subsidiaries, engages in the research and development, production, and sale of pesticide preparations. Its products include insecticides, fungicides, herbicides, plant growth regulators, fertilizers, and microbial fertilizers. The company is also engaged in the sales of agricultural machinery, fertilizers, and agricultural and sideline products, as well as offers technical consulting services. The company was founded in 1998 and is headquartered in Xi'an, China.

Contact Information

Address No. A19 Shiyang Industrial Park
No. 588, Caotan 3rd Road Economic Dev Zone, Weiyang District Xi'an,710018
China
Phone 86 29 8668 0383
Fax -

Top Executives

Name Age Since Title
Qiufang Zhang 56 2018 Director
Lijuan Han 45 2018 Deputy GM & Director
Xiaolong Fan - - Director
Zhonggang Yu - - Director
Shaowu Zhang 54 2018 Chairman of the Board
Tong Zhang 31 2018 GM & Director
Lijuan Han 46 2018 Director & Deputy GM
Zhonggang Yu 39 2019 Director
Xiaolong Fan 48 2018 Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

605033 Comments

Write your thoughts about Shaanxi Meibang Pharmaceutical Group Co Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email